Table 3.

Mean peak intensities of the most significant peaks differentiating BKVAN from other patient groups

ParameterNormalized Mean Peak Intensity (SD)
CM10
    m/z5.87211.31111.92912.72713.34923.482
    BKVAN25.8 (20.5)2.1 (1.8)26.5 (16.5)15.0 (8.4)5.8 (6.1)11.0 (8.2)
    AR13.1 (15.0)a1.3 (1.5)a14.9 (13.9)a7.2 (7.6)b2.07 (1.4)b9.1 (5.7)
    stable8.21 (11.9)c1.5 (1.9)a10.7 (10.3)b4.5 (5.1)c1.7 (0.9)c13.1 (5.4)
IMAC30
    m/z5.87211.31111.92912.72713.34923.482
    BKVAN15.6 (11.3)15.4 (8.1)27.9 (13.6)21.2 (11.4)6.7 (5.3)14.4 (11.9)
    AR10.9 (10.2)8.7 (6.3)b20.9 (13.7)14.5 (12.2)3.4 (2.6)a7.5 (7.6)
    stable7.9 (8.6)a8.3 (4.8)c19.8 (13.4)13.2 (11.2)b3.6 (3.1)a4.8 (5.5)b
  • a P < 0.05 versus BKVAN.

  • b P < 0.01 versus BKVAN.

  • c P = 0.001 versus BKVAN.